Using green tea extract to help women with fibroids improve fertility
3/4, University of Illinois at Chicago Clinical Site- Reproductive Medicine Collaborative Consortium: A randomized placebo-controlled trial of EGCG to improve fertility in women with uterine fibroids
This study is looking at whether a green tea extract called EGCG can help women with uterine fibroids reduce their fibroid size and improve their chances of getting pregnant, offering a natural treatment option for those who want to conceive.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10878669 on NIH RePORTER |
What this research studies
This research investigates the effects of a green tea extract called EGCG on women suffering from uterine fibroids, which can significantly impact fertility. The study involves a randomized, double-blind, placebo-controlled trial where participants will receive either EGCG or a placebo to assess its effectiveness in reducing fibroid size and improving chances of conception. By focusing on a non-hormonal treatment option, the research aims to provide a safer alternative for women who wish to conceive despite having fibroids. Participants will be monitored for changes in fibroid volume and overall fertility outcomes throughout the trial.
Who could benefit from this research
Good fit: Ideal candidates for this research are women of reproductive age who have been diagnosed with symptomatic uterine fibroids and are seeking to conceive.
Not a fit: Patients who do not have uterine fibroids or those who are not actively trying to conceive may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could offer a non-surgical and non-hormonal treatment option for women with fibroids, potentially improving their fertility.
How similar studies have performed: Previous studies have shown promising results with EGCG in reducing fibroid size, indicating that this approach may be effective.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Gonzalez, Frank — University of Illinois at Chicago
- Study coordinator: Gonzalez, Frank
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.